Zinc oxide and zinc salts have been proven to be very effective against a broad range of bacteria and viruses in in-vitro, in-vivo, and clinical studies.
Several mechanisms of action have been proposed to explain these activities which result in the damage of the cell membrane, proteins, eventually causing apoptosis. The most predominant of them consists in the generation of reactive oxygen species (ROS) such as hydroxyl radicals, superoxides, and hydrogen peroxide with high impact on the bacterial cell membrane or virus envelope. Due to the nonspecific mechanism of action, broad activity is observed with no resistant organism generation ever observed.
More relevant to our Sonomask is the fact it is not essential for Zinc oxide nanoparticles to penetrate the microbial cell to eliminate bacteria as well as Covid 19 and Sars viruses. Based on these premises, Dr. Aaron Garzon, Sonovia’s VP of R&D, is more than confident that our SonoMask will continue to be effective against any mutation of COVID-19 that are appearing now or will develop during the course of the pandemic.
We are humbled to have won the genesis prize 2020 for helping to make a difference during these challenging times.
When the WHO declared a world pandemic in January 2020, at Sonovia, we quickly applied our brightest minds and over 7 years of R&D to develop a face mask proven to comfortably protect users and their loved ones. Since Sonovia’s SonoMask has been trusted by over 200,000 customers, tens of thousands of masks have been donated to communities worldwide. All proceeds from this prize were donated to Elem – a local NGO that works for youth and raising awareness of their distress.